Mediphage Bioceuticals

Developing safe and effective gene delivery platforms to unlock the therapeutic power of personalized, redoseable genetic medicine.

Funding reportedLast round: Convertible note

BiotechnologyToronto, Canada

Follow Mediphage Bioceuticals and see its new rounds in your feed.Start following

What company datasets say Mediphage Bioceuticals raised

Funding, as reported

Reported in all4.1Min the source's currency

Rounds2

Last roundConvertible note

Last round dateMar 2019

Investors listed5

From Mediphage Bioceuticals's own website: 3 on the team.

Investors who name them

Each firm lists Mediphage Bioceuticals on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Startups like it

Add your raise, your deck and your story, and put Mediphage Bioceuticals in front of investors. Or tell us what we have wrong.